(Q40624643)

22 September 2017

1 reference

MDMA

0 references

title

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans (English)

1 reference

22 September 2017

1 reference

Steele TD

1

1 reference

22 September 2017

McCann UD

series ordinal

2

1 reference

22 September 2017

Ricaurte GA

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

89

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

539-551

1 reference

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Psychiatric illness associated with "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The psychological and physiological effects of MDMA on normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Stereochemistry of the metabolism of MDMA to MDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Further investigation of the discriminative stimulus properties of MDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Major metabolites of(±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

MDMA ("ecstasy") and panic disorder: induction by a single dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

MDMA (Ecstasy) precipitation of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Ecstasy-fueled 'rave' parties become dances of death for English youths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Discriminative profile of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The background and chemistry of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

MDMA transiently alters biogenic amines and metabolites in mouse brain and heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1994.TB03330.X

10.1111/J.1360-0443.1994.TB03330.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference